Skip to content

Clinical trials

Completed Phase 1 Hepatitis C, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 1 Status: Completed Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20051
20063
20077
20087
20096
20104
20118
20128
20138
20143
20151
20162
20171
20183
20192
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC8
Sunshine Lake Pharma Co., Ltd.6
Boehringer Ingelheim5
Hoffmann-La Roche5
Gilead Sciences4
Alios Biopharma Inc.3
Tanabe Pharma Corporation3
Bristol-Myers Squibb2
GlaxoSmithKline2
Presidio Pharmaceuticals, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic69
Hepatitis C20
Liver Diseases3
Hepatitis, Viral, Human2
Infections2
Virus Diseases2
Acquired Immunodeficiency Syndrome1
Flaviviridae Infections1
HIV Infections1
Hemophilia A1

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.